Pennsylvania · Nonprofit
The Institute For Cancer Research
The Institute For Cancer Research (Pennsylvania) receives grants from 92 organizations whose IRS filings report $26,401,192 to it, the largest being AMERICAN CANCER SOCIETY INC ($8,761,514). 53 of them have funded it in more than one year.
- Revenue FY2025
- $95M
- Funders on record
- 92
- Grants received
- $26M
- Net assets
- $110M
What The Institute For Cancer Research does
Mission
To prevail over cancer, marshaling heart and mind in bold scientific discovery, pioneering prevention and compassionate care.
As stated on its FY2025 Form 990.
Programs
The Institute for Cancer Research and its Research programs are renowned world-wide for their work in understanding both normal and abnormal cell growth. Scientists are involved in studies of genes that cause or inhibit cancer growth, virology, immunology, chemical carcinogens, cell growth and interaction and gene expression. In recent years, research has increasingly emphasized molecular oncology and genetics, areas which bridge advancing knowledge from the laboratory with new clinical approaches.
$63,248,978 spentof which $548,088 as grants$49,619,763 earned by the program88% of program spendingThe research facilities have been structured to fulfill the needs of the multi-disciplinary research programs at Fox Chase Cancer Center. The facilities have been designed to enhance ongoing research by supplying information, reagents, and technical expertise that are not readily available to the individual investigator.
$9,002,297 spent$1,562,609 earned by the program12% of program spending
The 2 programs described on its FY2024 Form 990, listed largest first by expense. Program spending in total: $72,251,275.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $164M to $183M (+11%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2017 1% · 2018 1% · 2019 1%. Grants only. Government contracts and fees sit inside program revenue.
45% of The Institute For Cancer Research’s revenue is contributions — more reliant on donations than three-quarters of its peers (7% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 4 of the last 9 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Dr Robert Uzzo
President & CEO
Board chair
Chip W Marshall III
Director/Chair
As listed on its FY2025 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 15 funders to 35 funders, grant income rose $1.2M → $3.9M.
19 of 92 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 26% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
Left out of every figure on this page: $151M from 3 payers (the payer shares this organization's board, largest The American Oncologic Hospital). These are real filings, and they are not money The Institute For Cancer Research raised.
From the IRS filings of The Institute For Cancer Research’s funders (the co-funder graph). Top 30 of 92 funders by total. Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
The Institute For Cancer Research has a broad base — no single funder exceeds 33% of grant income, and it takes 4 funders to reach half.
the vertical line marks half of all grant income — 4 funders to its left
95% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund The Institute For Cancer Research.
Largest funder’s share by year: 2017 67% · 2018 70% · 2019 34% · 2020 67% · 2021 21% · 2022 18% · 2023 38% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
41% of The Institute For Cancer Research's funders are still giving 3 years after their first grant; 58% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
The Institute For Cancer Research draws 82% of its grant income from funders outside Pennsylvania, across 21 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $6.7M arriving through sponsors registered in 16 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
The Institute For Cancer Research's funding base is broadening — from 15 funders to 35 as grant income climbed.
this organization peer median middle 50% of peers· 2,969 health nonprofits $10M–$100M, FY2025
Government funding The Institute For Cancer Research receives
Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $273.9M on record.
- Department of Health and Human Services$248.1M
- Department of Defense$25.2M
- National Science Foundation$604k
Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.
Organizations like The Institute For Cancer Research
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In Pennsylvania
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
69% of spending goes to programs.
Governance
Footprint & structure
Files a return copy in 2 states
Part of a family of 17 related entities
- Temple University of the Commonwealth System of Higher Ed · exempt
- Temple University Health System Inc · exempt
- Temple University Hospital Inc · exempt
- Temple Physicians Inc · exempt
- Temple Health Transport Team Inc · exempt
Screen this organization
A dated, signed PDF of the compliance screen for The Institute For Cancer Research: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds The Institute For Cancer Research?
- The Institute For Cancer Research (Pennsylvania) receives grants from 92 organizations whose IRS filings report $26,401,192 to it, the largest being AMERICAN CANCER SOCIETY INC ($8,761,514). 53 of them have funded it in more than one year.
- How many funders does The Institute For Cancer Research have?
- IRS filings report 92 organizations giving $26,401,192 in grants to The Institute For Cancer Research, 53 of which have funded it in more than one year.
- Who is the largest funder of The Institute For Cancer Research?
- AMERICAN CANCER SOCIETY INC is the largest funder on record, with $8,761,514 in grants. The full list of funders is on this page.
- How can an organization like The Institute For Cancer Research find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in Pennsylvania. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 92 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing